Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | protein tyrosine phosphatase, non-receptor type 6 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | CMGC family protein kinase | 0.0601 | 0.375 | 1 |
Schistosoma mansoni | protein kinase | 0.0601 | 0.375 | 0.375 |
Echinococcus multilocularis | casein kinase ii subunit alpha | 0.0601 | 0.375 | 0.375 |
Entamoeba histolytica | casein kinase, putative | 0.0601 | 0.375 | 0.5 |
Echinococcus granulosus | casein kinase ii subunit alpha | 0.0601 | 0.375 | 0.375 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0601 | 0.375 | 1 |
Echinococcus multilocularis | tyrosine protein phosphatase non receptor type | 0.0143 | 0.0202 | 0.0202 |
Echinococcus granulosus | tyrosine protein phosphatase non receptor type | 0.0143 | 0.0202 | 0.0202 |
Echinococcus granulosus | proto oncogene serine:threonine protein kinase | 0.1408 | 1 | 1 |
Plasmodium falciparum | casein kinase 2, alpha subunit | 0.0601 | 0.375 | 0.5 |
Echinococcus multilocularis | tyrosine protein phosphatase non receptor type | 0.0143 | 0.0202 | 0.0202 |
Loa Loa (eye worm) | CMGC/CK2 protein kinase | 0.0601 | 0.375 | 0.375 |
Toxoplasma gondii | CMGC kinase, CK2 family | 0.0601 | 0.375 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0601 | 0.375 | 1 |
Giardia lamblia | Kinase, CMGC CK2 | 0.0601 | 0.375 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0601 | 0.375 | 1 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0601 | 0.375 | 1 |
Plasmodium vivax | unspecified product | 0.0601 | 0.375 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0601 | 0.375 | 1 |
Echinococcus multilocularis | proto oncogene serine:threonine protein kinase | 0.1408 | 1 | 1 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.1408 | 1 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.1408 | 1 | 1 |
Loa Loa (eye worm) | CAMK/CAMKL/PASK protein kinase | 0.1175 | 0.8193 | 0.8193 |
Onchocerca volvulus | Serine\/threonine protein kinase homolog | 0.1408 | 1 | 1 |
Mycobacterium leprae | Possible transporter protein | 0.0117 | 0 | 0.5 |
Schistosoma mansoni | protein tyrosine phosphatase n11 (shp2) | 0.0143 | 0.0202 | 0.0202 |
Leishmania major | casein kinase II, putative | 0.0601 | 0.375 | 0.5 |
Trypanosoma brucei | Casein kinase II | 0.0601 | 0.375 | 1 |
Plasmodium vivax | casein kinase 2, alpha subunit, putative | 0.0601 | 0.375 | 0.5 |
Echinococcus granulosus | tyrosine protein phosphatase non receptor type | 0.0143 | 0.0202 | 0.0202 |
Brugia malayi | Casein kinase II, alpha chain | 0.0601 | 0.375 | 0.375 |
Brugia malayi | Serine/threonine-protein kinase Pim-3 | 0.1408 | 1 | 1 |
Loa Loa (eye worm) | CAMK/PIM protein kinase | 0.1408 | 1 | 1 |
Brugia malayi | Protein-tyrosine phosphatase containing protein | 0.0143 | 0.0202 | 0.0202 |
Entamoeba histolytica | protein kinase domain containing protein | 0.0601 | 0.375 | 0.5 |
Loa Loa (eye worm) | protein-tyrosine phosphatase | 0.0143 | 0.0202 | 0.0202 |
Trypanosoma cruzi | casein kinase II, putative | 0.0601 | 0.375 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0601 | 0.375 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | Inhibition of SHP2 (unknown origin) | ChEMBL. | 23942421 | |
IC50 (binding) | = 10.91 uM | Inhibition of SHP1 (unknown origin) | ChEMBL. | 23942421 |
IC50 (binding) | = 20.43 uM | Inhibition of TCPTP (unknown origin) | ChEMBL. | 23942421 |
IC50 (binding) | = 25.62 uM | Inhibition of PTP1B (unknown origin) | ChEMBL. | 23942421 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.